Germany's CureVac, the subject of a reported US overture, thrust into coronavirus spotlight

The U.S. government reportedly sought to access CureVac's vaccine research, deepening the intrigue surrounding the biotech, which just ousted its CEO.

Germany's CureVac, the subject of a reported US overture, thrust into coronavirus spotlight
The U.S. government reportedly sought to access CureVac's vaccine research, deepening the intrigue surrounding the biotech, which just ousted its CEO.